Clover Biopharmaceuticals, Ltd. (HKG:2197)
Hong Kong · Delayed Price · Currency is HKD 2.160
-0.080 (-3.57%)
Nov 4, 2025, 4:08 PM HKT
Clover Biopharmaceuticals Market Cap
Clover Biopharmaceuticals has a market cap or net worth of 2.8 billion as of November 4, 2025. Its market cap has increased by 517.31% in one year.
Market Cap
2.80B
Enterprise Value
2.38B
Revenue
56.73M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.16
Market Cap Chart
Since November 5, 2021, Clover Biopharmaceuticals's market cap has decreased from 15.03B to 2.80B, a decrease of -81.36%. That is a compound annual growth rate of -34.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2025 | 2.91B | 829.70% |
| Dec 31, 2024 | 312.59M | -61.08% |
| Dec 29, 2023 | 803.26M | -76.01% |
| Dec 30, 2022 | 3.35B | -78.71% |
| Dec 31, 2021 | 15.73B | 4.62% |
| Nov 5, 2021 | 15.03B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 266.84B |
| Hansoh Pharmaceutical Group Company | 216.01B |
| JD Health International | 194.65B |
| Innovent Biologics | 148.82B |
| WuXi Biologics | 141.38B |
| Sino Biopharmaceutical | 124.60B |
| Sichuan Kelun-Biotech Biopharmaceutical | 102.56B |
| Akeso | 102.43B |